Literature DB >> 8355584

Time response of cholesterol synthesis inhibition by compactin-related compounds. In vitro quantitation of the "escape phenomenon".

D D Sviridov1, A Endo, M Y Pavlov, V S Repin.   

Abstract

The time course of the inhibition of cholesterol synthesis by low and high doses of mevinolin and monacolin X were studied in normal human skin fibroblasts, fibroblasts without low density lipoprotein receptor and HepG2 hepatoma cells. Low doses of the inhibitors (0.2 ng/mL) caused a sharp decrease in the rate of cholesterol synthesis during the first 2-3 h, which gradually increased to about 40% during the next 6 h. Further incubation led to a decrease or stabilization of the cholesterol synthesis rate. High doses of the drugs (100 mg/mL) strongly inhibited cholesterol synthesis during the first 2-3 h, followed by a moderate increase during the next 20 h. No drug or tissue selectivity was observed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8355584     DOI: 10.1007/bf02536091

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  7 in total

1.  Multiple sterol regulatory elements in promoter for hamster 3-hydroxy-3-methylglutaryl-coenzyme A synthase.

Authors:  J R Smith; T F Osborne; M S Brown; J L Goldstein; G Gil
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

2.  [14C]acetate incorporation by cultured normal, familial hypercholesterolemia and Down's syndrome fibroblasts.

Authors:  R B Shireman; J Muth; J P Toth
Journal:  Biochim Biophys Acta       Date:  1988-02-19

3.  Cholesterol homeostasis in mononuclear leukocytes from patients with familial hypercholesterolemia treated with lovastatin.

Authors:  F C Hagemenas; D R Illingworth
Journal:  Arteriosclerosis       Date:  1989 May-Jun

4.  Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase.

Authors:  M S Brown; J R Faust; J L Goldstein; I Kaneko; A Endo
Journal:  J Biol Chem       Date:  1978-02-25       Impact factor: 5.157

5.  Comparison of the effect of six compactin-related compounds on cholesterol synthesis in five human cell types.

Authors:  D D Sviridov; A Endo; V S Repin; V N Smirnov
Journal:  Lipids       Date:  1990-11       Impact factor: 1.880

6.  Dihydromonacolin L and monacolin X, new metabolites which inhibit cholesterol biosynthesis.

Authors:  A Endo; K Hasumi; T Nakamura; M Kunishima; M Masuda
Journal:  J Antibiot (Tokyo)       Date:  1985-03       Impact factor: 2.649

7.  Lovastatin treatment inhibits sterol synthesis and induces HMG-CoA reductase activity in mononuclear leukocytes of normal subjects.

Authors:  B G Stone; C D Evans; W F Prigge; W C Duane; R L Gebhard
Journal:  J Lipid Res       Date:  1989-12       Impact factor: 5.922

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.